Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

310 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-01

Study Completion Date

2020-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multi-centre, international, non-interventional, prospective survey

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz

NCT01742884

Moderate Dry Eye Syndrome

COMPLETED PHASE4

DRy Eye Outcome and Prescription Study

NCT03652415

Dry Eye Dry Eye Syndrome Blepharitis +7 more

UNKNOWN

PMCF Study to Evaluate Performance and Safety of "Ocular Drops Based Upon Carmellose" Used to Relieve Dry Eye Symptoms

NCT05825352

Dry Eye Dry Eye Disease Kerato Conjunctivitis Sicca

COMPLETED NA

Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness

NCT06245421

Dry Eye

COMPLETED NA

A Study of TL-925 as a Treatment for Dry Eye Disease

NCT05745064

Dry Eye Disease

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To assess after 84 days, on a large scale patient population, the evaluation of ocular surface diseases and the satisfaction of dry eye disease (DED) treatment naïve patients or those who had to switch for tolerance, dissatisfaction or efficacy reasons to Thealoz® Duo.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thealoz Duo

Non applicable

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

sodium hyaluronate and trehalose

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All dry eye patients who require artificial tears or need to change their current artificial tears for any reason (i.e. due to dissatisfaction or low efficacy, etc…)
* Outpatients of either sex, aged at least 18 years
* Patients informed of the objectives of the survey and agreeing to participate.

Exclusion Criteria

* Use of cyclosporine, lifitegrast, tacrolimus, sirolimus within last 3 months and during the survey
* Use of topical ophthalmological treatments (glaucoma, etc…)
* Use of lacrimal plugs
* Ocular surgery in the last 12 months
* Concomitant use of corticosteroids
* Concomitant use of autologous serum or any blood derivatives
* Severe blepharitis
* Severe dry eye associated to

* Eyelid malposition
* Corneal dystrophy
* Ocular neoplasia
* Sjogren syndrome
* Any systemic pathologies
* Pregnancy/lactation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No